California start-up Bionaut Labs will conduct its first clinical trials on sending miniature robots deep inside the human skull to treat brain disorders
The tiny injectable robots can be guided through the brain using magnets.
Micro-robot technology "that used to be science fantasy in the 1950s and 1960s" is now "scientific fact," according to Michael Shpigelmacher, Bionaut Labs' founder and CEO.
Working with Germany's famed Max Planck research institutes, Bionaut Labs chose magnetic energy over optical or ultrasonic means to propel the robots because it is non-harmful to the human body.
Magnetic coils implanted outside the patient's skull are connected to a computer that can remotely and delicately navigate the micro-robot into the damaged area of the brain before withdrawing it the same way.
Unlike an MRI, the entire system is portable and utilizes 10 to 100 times less electricity.
The robot, which is a metal cylinder just a few millimeters long and shaped like a small bullet, follows a pre-programmed trajectory through a gel-filled container that mimics the density of the human brain in a simulation observed by AFP.
When the robot gets close enough to a pouch filled with blue liquid, it accelerates like a rocket and pierces the sack with its pointed end, allowing liquid to gush out.
When clinical trials begin in two years, the inventors want to use the robot to penetrate fluid-filled cysts in the brain.
The method could be used to cure Dandy-Walker Syndrome, a rare brain abnormality that affects youngsters if it is successful.
Cysts the size of a golf ball can form in congenital illness sufferers, swelling and increased pressure on the brain, initiating a slew of serious neurological problems.
Bionaut Labs has already tested its robots on large animals like lambs and pigs, and according to Shpigelmacher, "the evidence suggests that the technology is safe for us."
If approved, the robots could provide significant benefits over currently available therapies for brain illnesses.
Last year, the US Food and Drug Administration (FDA) awarded Bionaut Labs clearance to begin clinical studies for Dandy-Walker Syndrome and malignant gliomas, which are cancerous brain tumors that are frequently considered inoperable.
The micro-robots will be used to inject anti-cancer medications directly into brain tumors in a "surgical strike" in cancerous brain tumors.


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Instagram Outage Disrupts Thousands of U.S. Users
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 



